ecancermedicalscience

Conference Report

Aspirin for the next generation

2 Apr 2013
Nick Henderson, Tom Smith

First used as an analgesic and antipyretic, investigations into aspirin’s anti-inflammatory effects led to its establishment in 1974 as a drug that altered the activity of platelets to influence the course and incidence of myocardial infarction and cerebrovascular disease. It became the standard in treatment and prevention of vascular disorders.

The 25th International Scientific Meeting on aspirin held at the Royal College of Physicians in London on 24th October 2012 took aspirin into fresh fields, among them cancer, diabetes, dementia and gynaecology.

Related Articles

Foziya Mohammed Hussien, Anissa Mohammed Hassen, Zinet Abegaz Asfaw, Aragaw Yimer Ahmed, Yeshimebet Ali Dawed, Ahmed Hussien Asfaw, Erkihun Tadesse Amsalu, Hamid Yimam Hassen
Hardenson Rodríguez González, Sergio Andrade Mejía, Javier Orlando Contreras Ortiz, Adriana Patricia Osorno Gutiérrez, Jorge Eliécer Botero López, Javier Enrique Fox Quintana
S Gandini, PF Ferrucci, H Johanson, B Bonanni, A Testori